Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models

References

• Sidders B, Zhang P, Goodwin K, O’Connor G, Russell DL, Borodovsky A, Armenia J, McEwen R, Linghu B, Bendell JC, et al. Adenosine signaling is prognostic for cancer outcome and has predictive utility for immunotherapeutic response. Clin Cancer Res. 2020; 26(9):2176–15. PMID: 31953314. doi:10.1158/1078-0432.CCR-19-2183.
   PubMed Web of Science ®Google Scholar
• Blay J, White TD, Hoskin DW. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res. 1997 Jul 1;57(13):2602–5. PMID: 9205063.
   PubMed Web of Science ®Google Scholar
• Augustin RC, Leone RD, Naing A, Fong L, Bao R, Luke JJ. Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy. J Immunother Cancer. 2022;10(2):e004089. PMID: 35135866. doi:10.1136/jitc-2021-004089.
   PubMed Web of Science ®Google Scholar
• Wennerberg E, Spada S, Rudqvist NP, Lhuillier C, Gruber S, Chen Q, Zhang F, Zhou XK, Gross SS, Formenti SC, et al. CD73 blockade promotes dendritic cell infiltration of irradiated tumors and tumor rejection. Cancer Immunol Res. 2020;8(4):465–478. PMID: 32047024. doi:10.1158/2326-6066.CIR-19-0449.
   PubMed Web of Science ®Google Scholar
• Wennerberg E, Lhuillier C, Vanpouille-Box C, Pilones KA, García-Martínez E, Rudqvist NP, Formenti SC, Demaria S. Barriers to radiation-induced in situ tumor vaccination. Front Immunol. 2017 Mar 13; 8:229. PMID: 28348554. doi:10.3389/fimmu.2017.00229.
   PubMed Web of Science ®Google Scholar
• Coffelt SB, de Visser KE. Immune-mediated mechanisms influencing the efficacy of anticancer therapies. Trends Immunol. 2015;36(4):198–216. PMID: 25857662. doi:10.1016/j.it.2015.02.006.
   PubMed Web of Science ®Google Scholar
• Hay CM, Sult E, Huang Q, Mulgrew K, Fuhrmann SR, McGlinchey KA, Hammond SA, Rothstein R, Rios-Doria J, Poon E, et al. Targeting CD73 in the tumor microenvironment with MEDI9447. Oncoimmunol. 2016;5(8):e1208875. PMID: 27622077. doi:10.1080/2162402X.2016.1208875.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Majem M, Barlesi F, Carcereny E, Chu Q, Monnet I, Sanchez-Hernandez A, Dakhil S, Camidge DR, Winzer L, et al. COAST: An open-label, phase II, multidrug platform study of durvalumab alone or in combination with oleclumab or monalizumab in patients with unresectable, stage III non-small-cell lung cancer. J Clin Oncol. 2022;40(29):3383–3393. PMID: 35452273. doi:10.1200/JCO.22.00227.
   PubMed Web of Science ®Google Scholar
• A global study to assess the effects of durvalumab with oleclumab or durvalumab with monalizumab following concurrent chemoradiation in patients with stage III unresectable non-small cell lung cancer. https://clinicaltrials.gov/ct2/show/NCT05221840
   Google Scholar
• Xuan W, Qu Q, Zheng B, Xiong S, Fan GH. The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. J Leukoc Biol. 2015;97(1):61–9. PMID: 25359998. doi:10.1189/jlb.1A0314-170R.
   PubMed Web of Science ®Google Scholar
• Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautès-Fridman C, Fridman WH, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218. PMID: 27765066. doi:10.1186/s13059-016-1070-5.
   PubMed Web of Science ®Google Scholar
• Petitprez F, de Reyniès A, Keung EZ, Chen TW, Sun CM, Calderaro J, Jeng YM, Hsiao LP, Lacroix L, Bougoüin A, et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature. 2020;577(7791):556–560. PMID: 31942077. doi:10.1038/s41586-019-1906-8.
   PubMed Web of Science ®Google Scholar
• Voss MH, Hotson AN, Willingham S, Hughes BGM, Merchan JR, Fong L, Chu M, George S, Munneke B, Mobasher M, et al. CD68+ tumor-associated myeloid cells as the target of adenosine-induced gene products and predictor of response to adenosine blockade with ciforadenant (cifo) in renal cell cancer (RCC). J Clin Oncol. 2020;38(15_suppl):5025. doi:10.1200/JCO.2020.38.15_suppl.5025.
   Web of Science ®Google Scholar
• Chambers AM, Wang J, Lupo KB, Yu H, Atallah Lanman NM, Matosevic S. Adenosinergic signaling alters natural killer cell functional responses. Front Immunol.2018;9:2533. PMID: 30425720. doi:10.3389/fimmu.2018.02533.
   PubMed Web of Science ®Google Scholar
• Mastelic-Gavillet B, Navarro Rodrigo B, Décombaz L, Wang H, Ercolano G, Ahmed R, Lozano LE, Ianaro A, Derré L, Valerio M, et al. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells. J Immunother Cancer. 2019;7(1):257. PMID: 31601268. doi:10.1186/s40425-019-0719-5.
   PubMed Web of Science ®Google Scholar
• Tsukui H, Horie H, Koinuma K, Ohzawa H, Sakuma Y, Hosoya Y, Yamaguchi H, Yoshimura K, Lefor AK, Sata N, et al. CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model. BMC Cancer. 2020;20(1):411. PMID: 32397971. doi:10.1186/s12885-020-06893-3.
   PubMed Web of Science ®Google Scholar
• Nguyen AM, Zhou J, Sicairos B, Sonney S, Du Y. Upregulation of CD73 confers acquired radioresistance and is required for maintaining irradiation-selected pancreatic cancer cells in a mesenchymal state. Molecull Cellul Proteom: MCP. 2020;19(2):375–389. PMID: 31879272. doi:10.1074/mcp.RA119.001779.
   PubMed Web of Science ®Google Scholar
• Allard D, Chrobak P, Allard B, Messaoudi N, Stagg J. Targeting the CD73-adenosine axis in immuno-oncology. Immunol Lett.2019;205:31–39. PMID: 29758241. doi:10.1016/j.imlet.2018.05.001.
   PubMed Web of Science ®Google Scholar
• Magagna I, Gourdin N, Kieffer Y, Licaj M, Mhaidly R, Andre P, Morel A, Vincent-Salomon A, Paturel C, Mechta-Grigoriou F. CD73-mediated immunosuppression is linked to a specific fibroblast population that paves the way for new therapy in breast cancer. Cancers Basel. 2021;13(23):5878. PMID: 34884993. doi:10.3390/cancers13235878.
   PubMed Web of Science ®Google Scholar
• Yu M, Guo G, Huang L, Deng L, Chang CS, Achyut BR, Canning M, Xu N, Arbab AS, Bollag RJ, et al. CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint. Nat Commun. 2020;11(1):515. PMID: 31980601. doi:10.1038/s41467-019-14060-x.
   PubMed Web of Science ®Google Scholar
• Siew YY, Neo SY, Yew HC, Lim SW, Ng YC, Lew SM, Seetoh WG, Seow SV, Koh HL. Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity. Int Immunol. 2015;27(12):621–32. PMID: 26138671. doi:10.1093/intimm/dxv041.
   PubMed Web of Science ®Google Scholar
• Dosset M, Vargas TR, Lagrange A, Boidot R, Végran F, Roussey A, Chalmin F, Dondaine L, Paul C, Lauret Marie-Joseph E, et al. PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer. Oncoimmunol. 2018;7(6):e1433981. PMID: 29872568. doi:10.1080/2162402X.2018.1433981.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nat Rev Immunol. 2015;15(7):405–14. doi:10.1038/nri3845. PMID: 26027717.
   PubMed Web of Science ®Google Scholar
• Wischhusen J, Melero I, Fridman WH. Growth/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front Immunol. 2020;11:951. PMID: 32508832. doi:10.3389/fimmu.2020.00951.
   PubMed Web of Science ®Google Scholar
• Breen DM, Kim H, Bennett D, Calle RA, Collins S, Esquejo RM, He T, Joaquim S, Joyce A, Lambert M, et al. GDF-15 neutralization alleviates platinum-based chemotherapy-induced emesis, anorexia, and weight loss in mice and nonhuman primates. Cell Metab. 2020;32(6):938–950.e6. PMID: 33207247. doi:10.1016/j.cmet.2020.10.023.
   PubMed Web of Science ®Google Scholar
• Marcovecchio PM, Thomas G, Salek-Ardakani S. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer. J Immunother Cancer. 2021;9(2):e002045. PMID: 33637602. doi:10.1136/jitc-2020-002045.
   PubMed Web of Science ®Google Scholar
• Qu Y, Wen J, Thomas G, Yang W, Prior W, He W, Sundar P, Wang X, Potluri S, Salek-Ardakani S. Baseline frequency of inflammatory Cxcl9-expressing tumor-associated macrophages predicts response to avelumab treatment. Cell Rep. 2020;32(1):107873. PMID: 32640238. doi:10.1016/j.celrep.2020.107873.
   PubMed Web of Science ®Google Scholar
• Chow MT, Ozga AJ, Servis RL, Frederick DT, Lo JA, Fisher DE, Freeman GJ, Boland GM, Luster AD. Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy. Immunity. 2019;50(6):1498–1512.e5. PMID: 31097342. doi:10.1016/j.immuni.2019.04.010.
   PubMed Web of Science ®Google Scholar
• Snodgrass RG, Zezina E, Namgaladze D, Gupta S, Angioni C, Geisslinger G, Lütjohann D, Brüne B. A novel function for 15-lipoxygenases in cholesterol homeostasis and CCL17 production in human macrophages. Front Immunol. 2018;9:1906. PMID: 30197642. doi:10.3389/fimmu.2018.01906.
   PubMed Web of Science ®Google Scholar
• Eggink LL, Roby KF, Cote R, Kenneth Hoober J. An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides. J Immunother Cancer. 2018;6(1):28. PMID: 29665849. doi:10.1186/s40425-018-0339-5.
   PubMedGoogle Scholar
• Yabe R, Chung SH, Murayama MA, Kubo S, Shimizu K, Akahori Y, Maruhashi T, Seno A, Kaifu T, Saijo S, et al. TARM1 contributes to development of arthritis by activating dendritic cells through recognition of collagens. Nat Commun. 2021;12(1):94. PMID: 33397982. doi:10.1038/s41467-020-20307-9.
   PubMed Web of Science ®Google Scholar
• Ma RY, Black A, Qian BZ. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol. 2022;43(7):546–563. PMID: 35690521. doi:10.1016/j.it.2022.04.008.
   PubMed Web of Science ®Google Scholar
• Lu L, Li J, Moussaoui M, Boix E. Immune modulation by human secreted RNases at the extracellular space. Front Immunol. 2018;9:1012. PMID: 29867984. doi:10.3389/fimmu.2018.01012.
   PubMed Web of Science ®Google Scholar
• Moore SF, MacKenzie AB. NADPH oxidase NOX2 mediates rapid cellular oxidation following ATP stimulation of endotoxin-primed macrophages. J Immunol. 2009;183(5):3302–8. PMID: 19696433. doi:10.4049/jimmunol.0900394.
   PubMed Web of Science ®Google Scholar
• Wu Q, Allouch A, Paoletti A, Leteur C, Mirjolet C, Martins I, Voisin L, Law F, Dakhli H, Mintet E, et al. NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy. Cell Death Differ. 2017;24(9):1632–1644. PMID: 28574504. doi:10.1038/cdd.2017.91.
   PubMed Web of Science ®Google Scholar
• Fridman WH, Petitprez F, Meylan M, Chen TW, Sun CM, Roumenina LT, Sautès-Fridman C. B cells and cancer: to B or not to B? J Exp Med. 2021;218(1):e20200851. PMID: 33601413. doi:10.1084/jem.20200851.
   PubMed Web of Science ®Google Scholar
• Griss J, Bauer W, Wagner C, Simon M, Chen M, Grabmeier-Pfistershammer K, Maurer-Granofszky M, Roka F, Penz T, Bock C, et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat Commun. 2019;10(1):4186. PMID: 31519915. doi:10.1038/s41467-019-12160-2.
   PubMed Web of Science ®Google Scholar
• Bruni D, Angell HK, Galon J. The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 2020;20(11):662–680. PMID: 32753728. doi:10.1038/s41568-020-0285-7.
   PubMed Web of Science ®Google Scholar
• Hair J, Garcon F, Hsueh M, Dallaway L, Bibikova E, Torchia MLG, Moody G, Schuller A, Dovedi SJ, Cooper ZA, et al. Abstract 1695: activation of B cells by CD73 blocking antibodies. Cancer Res. 2021;81(13_Supplement):1695. doi:10.1158/1538-7445.AM2021-1695.
   PubMed Web of Science ®Google Scholar
• Luke J, Merchan J, Hughes B, Sosman J, Tripathi A, Puzanov I, Marron T, Marrone K, Hill C, Janc J, et al. 701 Activating CD73 on B cells as a target for immunotherapy of COVID-19 and viral associated cancers: clinical activity in human papilloma virus positive (HPV) head and neck squamous cell cancers (HNSCC). J Immunother Cancer. 2021;9(Suppl 2):A729. doi:10.1136/jitc-2021-SITC2021.701.
   Google Scholar
• Gao Q, Wang S, Chen X, Cheng S, Zhang Z, Li F, Huang L, Yang Y, Zhou B, Yue D, et al. Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC. J Immunother Cancer. 2019;7(1):42. PMID: 30744691. doi:10.1186/s40425-019-0511-6.
   PubMed Web of Science ®Google Scholar
• Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformat. 2013;29(1):15–21. PMID: 23104886. doi:10.1093/bioinformatics/bts635.
   Google Scholar
• Putri GH, Anders S, Pyl PT, Pimanda JE, Zanini F, Boeva V. Analysing high-throughput sequencing data in python with HTSeq 2.0. Bioinformat. 2022;38(10):2943–2945. PMID: 35311944. doi:10.1093/bioinformatics/btac166.
   Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. PMID: 25516281. doi:10.1186/s13059-014-0550-8.
   PubMed Web of Science ®Google Scholar
• Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A. Fast gene set enrichment analysis. bioRxiv. 2021:60012. doi:10.1101/060012v3.
   Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–50. PMID: 16199517. doi:10.1073/pnas.0506580102.
   PubMed Web of Science ®Google Scholar
• Bioconductor - topGO. https://bioconductor.org/packages/release/bioc/html/topGO.html
   Google Scholar
• Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovat (Camb). 2021;2(3):100141. PMID: 34557778. doi:10.1016/j.xinn.2021.100141.
   PubMedGoogle Scholar
• Dannhorn A, Kazanc E, Ling S, Nikula C, Karali E, Serra MP, Vorng JL, Inglese P, Maglennon G, Hamm G, et al. Universal sample preparation unlocking multimodal molecular tissue imaging. Anal Chem. 2020;92(16):11080–11088. PMID: 32519547. doi:10.1021/acs.analchem.0c00826.
   PubMed Web of Science ®Google Scholar
• Race AM, Styles IB, Bunch J. Inclusive sharing of mass spectrometry imaging data requires a converter for all. J Proteomics. 2012;75(16):5111–5112. PMID: 22641155. doi:10.1016/j.jprot.2012.05.035.
   PubMed Web of Science ®Google Scholar